ANDA 214473, held by Aurobindo Pharma Ltd. Esomeprazole Magnesium.
As of Nov 16, 2026, ANDA 214473 (Esomeprazole Magnesium), held by Aurobindo Pharma Ltd, was first approved by FDA on Jul 12, 2023, with 0 approved supplements and 0 published complete response letters.
Uses treats frequent heartburn (occurs 2 or more days a week) not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 12, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Esomeprazole MagnesiumEQ 20MG BASE · tablet, delayed release;oral | Esomeprazole Magnesium | OTC |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters